umu.sePublications
Change search
Link to record
Permanent link

Direct link
BETA
Norgren, Nina
Publications (7 of 7) Show all publications
Norgren, N., Olsson, M., Nyström, H., Ericzon, B. G., de Tayrac, M., Genin, E., . . . Suhr, O. B. (2014). Gene expression profile in hereditary transthyretin amyloidosis: differences in targeted and source organs. Amyloid: Journal of Protein Folding Disorders, 21(2), 113-119
Open this publication in new window or tab >>Gene expression profile in hereditary transthyretin amyloidosis: differences in targeted and source organs
Show others...
2014 (English)In: Amyloid: Journal of Protein Folding Disorders, ISSN 1350-6129, E-ISSN 1744-2818, Vol. 21, no 2, p. 113-119Article in journal (Refereed) Published
Abstract [en]

Introduction: Hereditary transthyretin amyloidosis (ATTR) is a genetic disease caused by a point mutation in the TTR gene that causes the liver to produce an unstable TTR protein. The most effective treatment has been liver transplantation in order to replace the variant TTR producing liver with one that produces only wild-type TTR. ATTR amyloidosis patients' livers are reused for liver sick patients, i.e. the Domino procedure. However, recent findings have demonstrated that ATTR amyloidosis can develop in the recipients within 7-8 years. The aim of this study was to elucidate how the genetic profile of the liver is affected by the disease, and how amyloid deposits affect target tissue. Methods: Gene expression analysis was used to unravel the genetic profiles of Swedish ATTR V30M patients and controls. Biopsies from adipose tissue and liver were examined. Results and Conclusions: ATTR amyloid patients' gene expression profile of the main source organ, the liver, differed markedly from that of the controls, whereas the target organs' gene expression profiles were not markedly altered in the ATTR amyloid patients compared to those of the controls. An impaired ER/protein folding pathway might suggest ER overload due to mutated TTR protein.

Keywords
Adipose tissue, familial amyloidosis, liver tissue, PCA, Simca, V30M
National Category
Medical Genetics
Identifiers
urn:nbn:se:umu:diva-90410 (URN)10.3109/13506129.2014.894908 (DOI)000336146700007 ()
Note

Originally included in thesis in manuscript form.

Available from: 2014-07-10 Created: 2014-06-23 Last updated: 2018-06-07Bibliographically approved
Norgren, N. (2014). Hereditary transthyretin amyloidosis (ATTR V30M): from genes to genealogy. (Doctoral dissertation). Umeå: Umeå Universitet
Open this publication in new window or tab >>Hereditary transthyretin amyloidosis (ATTR V30M): from genes to genealogy
2014 (English)Doctoral thesis, comprehensive summary (Other academic)
Alternative title[sv]
Ärftlig transtyretinamyloidos (Skelleftesjukan) : från arvsanlag till släktträd
Abstract [en]

Background: Hereditary transthyretin amyloidosis is an autosomal dominant disease with a reduced penetrance. The most common mutation in Sweden is the V30M mutation in the transthyretin gene. Clustering areas of the disease can be found in Northern Sweden, Portugal, Brazil and Japan, although sporadic cases exist worldwide. Despite being caused by the same mutation, there are large differences in onset, penetrance and symptoms of the disease. Swedish V30M patients typically have a later onset with a lower penetrance compared to those from the clustering Portuguese V30M areas. The reasons for these differences have not been fully understood. The aim of this thesis is to study mechanisms that may influence onset and symptoms and investigate why patients carrying the same mutation have different phenotypes.

Methods: Genealogy studies were performed on all known V30M carriers in Sweden using standard genealogy methods. DNA samples from patients, asymptomatic carriers and controls from different countries were collected and the transthyretin gene was sequenced. Liver biopsies from patients were used for allele specific expression analysis and a cell assay was used for miRNA analysis with the mutated allele. Gene expression analysis was performed on biopsies from liver and fat from patients and controls.

Results and conclusions: Genealogic analysis of all known Swedish V30M carriers managed to link together 73% of the Swedish ATTR V30M population to six different ancestors from the 17th and 18th century, thus dating the Swedish V30M mutation to be more than 400 years old. A founder effect was also visible in descendants to one of the ancestors, producing a later age at onset. Sequencing of the transthyretin gene revealed a SNP in the 3’ UTR of all Swedish V30M carriers that was not found in any of the Japanese or French V30M carriers. The SNP was present on the Swedish transthyretin haplotype and defined the Swedish V30M population as separate from others. However, the SNP itself had no effect upon phenotype or onset of disease. Gene expression analysis of liver and fat tissue revealed a change in genetic profile of the patients’ livers, in contrast to the unchanged profile of the fat tissue. A changed genetic profile of the liver could explain why domino liver recipients develop the disease much earlier than expected.

Place, publisher, year, edition, pages
Umeå: Umeå Universitet, 2014. p. 49
Series
Umeå University medical dissertations, ISSN 0346-6612 ; 1622
Keywords
Hereditary transthyretin amyloidosis, Familial amyloid polyneuropathy, transthyretin, genealogy, founder effect, miRNA, allele-specific expression, gene expression, liver
National Category
Medical Genetics
Research subject
Medicine
Identifiers
urn:nbn:se:umu:diva-84494 (URN)978-91-7459-786-8 (ISBN)
Public defence
2014-01-31, Sal D, 9 trappor, byggnad 1D, Norrlands Universitetssjukhus, Umeå, 09:00 (English)
Opponent
Supervisors
Available from: 2014-01-10 Created: 2014-01-08 Last updated: 2018-06-08Bibliographically approved
Norgren, N., Hellman, U., Ericzon, B. G., Olsson, M. & Suhr, O. B. (2012). Allele specific expression of the transthyretin gene in Swedish patients with hereditary transthyretin amyloidosis (ATTR V30M) is similar between the two alleles. PLoS ONE, 7(11), e49981
Open this publication in new window or tab >>Allele specific expression of the transthyretin gene in Swedish patients with hereditary transthyretin amyloidosis (ATTR V30M) is similar between the two alleles
Show others...
2012 (English)In: PLoS ONE, ISSN 1932-6203, E-ISSN 1932-6203, Vol. 7, no 11, p. e49981-Article in journal (Refereed) Published
Abstract [en]

Background: Hereditary transthyretin (TTR) amyloidosis (ATTR) is an autosomal dominant disease characterized by extracellular deposits of amyloid fibrils composed of misfolded TTR. The differences in penetrance and age at onset are vast, both between and within populations, with a generally late onset for Swedish carriers. In a recent study the entire TTR gene including the 3' UTR in Swedish, French and Japanese ATTR patients was sequenced. The study disclosed a SNP in the V30M TTR 3' UTR of the Swedish ATTR population that was not present in either the French or the Japanese populations (rs62093482-C > T). This SNP could create a new binding site for miRNA, which would increase degradation of the mutated TTR's mRNA thus decrease variant TTR formation and thereby delay the onset of the disease. The aim of the present study was to disclose differences in allele specific TTR expression among Swedish V30M patients, and to see if selected miRNA had any effect upon the expression.

Methodology/Principal Findings: Allele-specific expression was measured on nine liver biopsies from Swedish ATTR patients using SNaPshot Multiplex assay. Luciferase activity was measured on cell lines transfected with constructs containing the TTR 3' UTR. Allele-specific expression measured on liver biopsies from Swedish ATTR patients showed no difference in expression between the two alleles. Neither was there any difference in expression between cell lines co-transfected with two constructs with or without the TTR 3' UTR SNP regardless of added miRNA.

Conclusions/Significance: The SNP found in the 3' UTR of the TTR gene has no effect on degrading the variant allele's expression and thus has no impact on the diminished penetrance of the trait in the Swedish population. However, the 3' UTR SNP is unique for patients descending from the Swedish founder, and this SNP could be utilized to identify ATTR patients of Swedish descent.

National Category
Clinical Medicine
Identifiers
urn:nbn:se:umu:diva-63028 (URN)10.1371/journal.pone.0049981 (DOI)000311333800064 ()23185504 (PubMedID)
Available from: 2012-12-28 Created: 2012-12-27 Last updated: 2018-06-08Bibliographically approved
Norgren, N., Mattson, E., Forsgren, L. & Holmberg, M. (2011). A high-penetrance form of late-onset torsion dystonia maps to a novel locus (DYT21) on chromosome 2q14.3-q21.3. Neurogenetics, 12(2), 137-143
Open this publication in new window or tab >>A high-penetrance form of late-onset torsion dystonia maps to a novel locus (DYT21) on chromosome 2q14.3-q21.3
2011 (English)In: Neurogenetics, ISSN 1364-6745, E-ISSN 1364-6753, Vol. 12, no 2, p. 137-143Article in journal (Refereed) Published
Abstract [en]

The primary dystonias are a genetically heterogeneous group of disorders that can be subdivided in pure dystonias, dystonia-plus syndromes, and paroxymal dystonia. Four pure autosomal dominant dystonia loci have been mapped to date, DYT1, 6, 7, and 13, with varying penetrance. We report the mapping of a novel locus for a late-onset form of pure torsion dystonia in a family from northern Sweden. The disease is inherited in an autosomal dominant manner with a penetrance that may be as high as 90%. The torsion dystonia locus in this family was mapped to chromosome 2q14.3-q21.3 using an Illumina linkage panel. We also confirmed the linkage, using ten tightly linked microsatellite markers in the region, giving a maximum LOD score of 5.59 for marker D2S1260. The disease-critical region is 3.6-8.9 Mb depending on the disease status of one individual carrying a centromeric recombination. Mutational analysis was performed on 22 genes in the disease-critical region, including all known and hypothetical genes in the smaller, 3.6-Mb region, but no disease-specific mutations were identified. Copy number variation analysis of the region did not reveal any deletions or duplications. In order to increase the chances of finding the disease gene, fine-mapping may be necessary to decrease the region of interest. This report will hopefully result in the identification of additional dystonia families with linkage to the same locus, and thereby, refinement of the disease critical region.

Place, publisher, year, edition, pages
Heidelberg: Springer Berlin/Heidelberg, 2011
Keywords
Dystonia, Late-onset, Autosomal dominant, Mapping
National Category
Medical Genetics
Identifiers
urn:nbn:se:umu:diva-57021 (URN)10.1007/s10048-011-0274-9 (DOI)21301909 (PubMedID)
Available from: 2012-07-02 Created: 2012-07-02 Last updated: 2018-06-08Bibliographically approved
Olsson, M., Norgren, N., Obayashi, K., Plante-Bordeneuve, V., Suhr, O. B., Cederquist, K. & Jonasson, J. (2010). A possible role for miRNA silencing in disease phenotype variation in Swedish transthyretin V30M carriers. BMC Medical Genetics, 11, 130
Open this publication in new window or tab >>A possible role for miRNA silencing in disease phenotype variation in Swedish transthyretin V30M carriers
Show others...
2010 (English)In: BMC Medical Genetics, ISSN 1471-2350, E-ISSN 1471-2350, Vol. 11, p. 130-Article in journal (Refereed) Published
Abstract [en]

Our results are the first to show the presence of a 3'UTR polymorphism on the V30M haplotype in Swedish carriers, which can serve as a miRNA binding site potentially leading to down-regulated expression from the mutated TTR allele. This finding may be related to the low penetrance and high age at onset of the disease observed in the Swedish patient population.

Keywords
Allele Frequency; Amyloidosis; Amyloid Neuropathies, Familial; Humans; MicroRNA; Polymorphism, Single Nucleotide; Transthyretin; 3' Untranslated Regions/genetics
National Category
Medical Genetics
Research subject
Genetics
Identifiers
urn:nbn:se:umu:diva-39677 (URN)10.1186/1471-2350-11-130 (DOI)000283195800001 ()20840742 (PubMedID)
Available from: 2011-02-03 Created: 2011-02-03 Last updated: 2018-06-08Bibliographically approved
Olsson, M., Norgren, N., Saraiva, M. J., Cederquist, K., Jonasson, J. & Suhr, O. B.Distribution of mitochondrial DNA haplogroups in Portuguese familial amyloidosis with polyneuropathy (FAP) patients.
Open this publication in new window or tab >>Distribution of mitochondrial DNA haplogroups in Portuguese familial amyloidosis with polyneuropathy (FAP) patients
Show others...
(English)Manuscript (preprint) (Other academic)
Keywords
Amyloidosis-hereditary-neuropathic; mitochondrial haplogroup; transthyretin
National Category
Medical Genetics
Research subject
Genetics
Identifiers
urn:nbn:se:umu:diva-34125 (URN)
Available from: 2010-05-12 Created: 2010-05-12 Last updated: 2018-06-08Bibliographically approved
Norgren, N., Andersson Escher, S., Lundgren, H.-E., Suhr, O. B. & Olsson, M.Genealogic studies of the Swedish hereditary transthyretin amyloidosis (ATTR V30M) population: differences in age at onset within the population.
Open this publication in new window or tab >>Genealogic studies of the Swedish hereditary transthyretin amyloidosis (ATTR V30M) population: differences in age at onset within the population
Show others...
(English)Manuscript (preprint) (Other academic)
Keywords
Hereditary transthyretin amyloidosis, genealogy, V30M, transthyretin
National Category
Medical Genetics
Research subject
Medicine
Identifiers
urn:nbn:se:umu:diva-84482 (URN)
Available from: 2014-01-08 Created: 2014-01-08 Last updated: 2018-06-08Bibliographically approved
Organisations

Search in DiVA

Show all publications